Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David N Neubauer

Showing results (1-10 of 34) with videos related to

Pageof 4
Sort By:
Clinical Cornerstone|November 25, 2003
Pharmacologic approaches for the treatment of chronic insomniaDavid N Neubauer
Clinical Cornerstone|November 17, 2004
Chronic insomnia: current issuesDavid N Neubauer
Expert Opinion on Investigational Drugs|September 28, 2005
Indiplon: the development of a new hypnoticDavid N Neubauer
Nature and Science of Sleep|April 26, 2013
ZolpiMist™: a new formulation of zolpidem tartrate for the short-term treatment of insomnia in the USDavid N Neubauer
Postgraduate Medicine|November 27, 2009
Sleep-disordered breathing and all-cause mortality in the sleep heart health study. CommentaryDavid N Neubauer
Nature Clinical Practice. Neurology|May 22, 2008
Zolpidem extended-release in the long-term treatment of insomniaDavid N Neubauer
Nature Clinical Practice. Neurology|August 26, 2006
Does modafinil safely and effectively treat shift-work sleep disorder?David N Neubauer
Current Opinion in Investigational Drugs (London, England : 2000)|January 5, 2010
Almorexant, a dual orexin receptor antagonist for the treatment of insomniaDavid N Neubauer
Continuum (Minneapolis, Minn.)|February 7, 2013
Chronic insomniaDavid N Neubauer
Managed Care (Langhorne, Pa.)|May 29, 2008
State-of-the-art sleep managementDavid N Neubauer
Pageof 4

Showing results (1-10 of 34) with videos related to

Sort By:
Pageof 4
Clinical Cornerstone|November 25, 2003
Pharmacologic approaches for the treatment of chronic insomniaDavid N Neubauer
Clinical Cornerstone|November 17, 2004
Chronic insomnia: current issuesDavid N Neubauer
Expert Opinion on Investigational Drugs|September 28, 2005
Indiplon: the development of a new hypnoticDavid N Neubauer
Nature and Science of Sleep|April 26, 2013
ZolpiMist™: a new formulation of zolpidem tartrate for the short-term treatment of insomnia in the USDavid N Neubauer
Postgraduate Medicine|November 27, 2009
Sleep-disordered breathing and all-cause mortality in the sleep heart health study. CommentaryDavid N Neubauer
Nature Clinical Practice. Neurology|May 22, 2008
Zolpidem extended-release in the long-term treatment of insomniaDavid N Neubauer
Nature Clinical Practice. Neurology|August 26, 2006
Does modafinil safely and effectively treat shift-work sleep disorder?David N Neubauer
Current Opinion in Investigational Drugs (London, England : 2000)|January 5, 2010
Almorexant, a dual orexin receptor antagonist for the treatment of insomniaDavid N Neubauer
Continuum (Minneapolis, Minn.)|February 7, 2013
Chronic insomniaDavid N Neubauer
Managed Care (Langhorne, Pa.)|May 29, 2008
State-of-the-art sleep managementDavid N Neubauer
Pageof 4